← peptides typeshit

CSPI urges FDA to reject advisory panel vote to allow compounding of six peptides

The group says panel members tied to peptide businesses outvoted FDA staff scientists, who had advised keeping all seven peptides off the 503A list.

Read at Center for Science in the Public Interest

Recap by typeshit. Full story at Center for Science in the Public Interest.